Mathematical model simulations may assist in the selection of mechanical ventilator settings. Previously, simulations have been limited to control ventilator modes, as these models lacked representation of respiratory control. This paper presents integration of a chemoreflex respiratory control model with models describing: ventilation and pulmonary gas exchange; oxygenation and acid-base status of blood; circulation; interstitial fluid and tissue buffering; and metabolism. A sensitivity analysis showed that typical response to changing ventilator settings can be described by base excess (BE), production of CO2 (V̇CO 2 ), and model parameters describing central chemoreceptor behavior. Since BE and V̇CO 2 , can be routinely measured, changes in ventilator support may therefore be used to identify patient-specific chemoreceptor drive, enabling patient-specific predictions of the response to changes in mechanical ventilation. 
INTRODUCTION
Setting mechanical ventilation is a difficult and timeconsuming process. Poor settings can increase the time spent on mechanical ventilation, and the risk of lung injury and mortality (Arnal et al., 2012) . Consequently, Decision Support Systems (DSS) have been developed to advise upon or automate the selection of mechanical ventilator settings (Tehrani and Roum, 2008a) . These include rule-based systems such as the commercially-available SmartCare and Adaptive Support Ventilation (ASV) systems. SmartCare has been shown to be effective for managing pressure support ventilation to keep the end tidal partial pressure of CO2 (PET CO 2 ) and respiratory frequency (fR) within a comfort zone (Lellouche et al., 2006) , and ASV has been shown appropriate for selecting ventilator settings that minimize the inspiratory work of breathing (Iotti et al., 2010) . Research systems have also been developed based upon mathematical physiological models rather than rules, these including SOPAVent (Wang et al., 2010) , Flex (Tehrani and Roum, 2008b ) and the Intelligent Ventilator (INVENT) project (Rees, 2011) . The potential advantage of such systems is that the physiological models can be tuned to the individual patient and used to simulate the patient's response to changes in mechanical ventilation, a useful process when selecting optimal ventilator settings.
To develop a model-based DSS for selecting optimal mechanical ventilator settings requires mathematical models of: 1) ventilation and pulmonary gas exchange; 2) oxygenation and acid-base status of blood; 3) circulation; 4) metabolism and 5) respiratory control. Using such models it should be possible to simulate the effects of changes in mechanical ventilation combined with the effects of, for example: changes in CO2 production (V̇CO 2 ) or O2 consumption (V̇O 2 ); metabolic acidosis or alkalosis; impairment of gas exchange; and changes in respiratory drive due to sedation. The DSS INVENT includes all of these model components with the exception of a model of respiratory control (Rees, 2011) . The absence of a model of respiratory control limits it use to fully sedated patients in controlled ventilator modes. As these patients represent only a small fraction presenting in the ICU, further development of the system to include a model of respiratory control is essential if the system is to have routine clinical application. This paper presents the integration of a mathematical model of respiratory control (Duffin, 2005; Ainslie and Duffin, 2009) into the current INVENT set of models. The integrated model of respiratory control needs to be a) sufficiently complex to represent physiology adequately, and b) sufficiently simple to be tuned to the individual patient from routinely available clinical data. Accordingly, the paper has two objectives: 1) to postulate which respiratory control model parameters can be identifiable from patient data; and 2) to evaluate whether the model is sufficiently complex by exploring its ability to simulate the respiratory response to changes in ventilator support considering different levels of V̇CO 2 and different blood acid-base states, represented by arterial base excess (BEa). Figure 1 illustrates the set of mathematical model components of INVENT including the mathematical representation of respiratory control. Figure 1A illustrates the structure of the model of ventilation and pulmonary gas exchange. This model has previously been shown to be identifiable from clinical data Fig. 1 . Structure of the integrated model of respiratory control. The model includes sub-models of: ventilation and pulmonary gas exchange (A); oxygenation and acid-base status of blood (B); acid-base status of CSF (C); cardiac output, arterial and mixed venous pools (D); interstitial fluid and tissue buffering, and metabolism (E); and chemoreflex respiratory control (F).
METHODS

Model description and calibration
on the variation of FIO 2 , and has been used to describe changes in gas exchange in numerous clinical situations (Karbing et al., 2007; Karbing et al., 2011) . Figure 1B illustrates the structure of the model of oxygenation and blood acid-base status. This model has been shown to accurately describe the addition or removal of O2, CO2 or strong acid to blood and also to describe the mixing of different blood samples (Rees et al., 2010) . Figure 1C describes Duffin's model of cerebrospinal fluid (CSF) acid-base with the model constants listed in table 1. This model incorporates Stewart's and Watson's mass-action equations describing water, phosphate and albumin dissociation (1-3), formation of bicarbonate and carbonate (4-5), and electrical neutrality (6) (Duffin, 2005) . In addition, the partial pressure of CO2 in CSF (PcsfCO 2 ) is set equivalent to that in arterial blood (PaCO 2 ) plus an increase due to the brain production of CO2 (V̇bCO 2 ) (7) (Anslie and Duffin, 2009 The model illustrated in Figure 1 includes compartments representing CO2 transport and storage including the arterial and venous compartments, and circulation represented as cardiac output (Q̇) ( Figure 1D ). Figure 1E shows the model of interstitial fluid and tissue buffering, and metabolism included in the system . This model includes the bicarbonate and non-bicarbonate buffers in these relatively large volumes, V̇O 2 and V̇CO 2 . Figure 1F illustrates the model of respiratory control (9-12), with small adaptations and calibrations necessary for integration with the other models described as follows. The peripheral drive (Dp) is a linear function of the difference between the arterial hydrogen ion concentration ([H + a]) and the peripheral threshold (Tp) (9). The slope of this function is the sensitivity of the peripheral chemoreceptors (Sp), which is modulated by PaO 2 as described by (10). Dp is allowed to have negative values up to -1 l min -1
. In this way, the model includes an offset to allow disfacilitation of peripheral drive when [H + a] falls below Tp, as suggested previously (Mohan and Duffin, 1997; Ursino et al., 2001; Day and Wilson, 2008 -1 and P0=4 kPa to describe O2 modulation of Sp. This model includes five parameters, two chemoreceptor sensitivities (Sp, Sc), two chemoreceptor thresholds (Tc, Tp), and wakefulness drive (Dw).
Equation (12) describes the alveolar ventilation (V̇A) as the sum of the two chemoreflex drives and wakefulness drive (Dw). Dw is the behavioral component of ventilation, and is considered independent of the chemoreflex respiratory control, but dependent on state of conscious. Dw=0 l min -1 represents unconscious breathing, and Dw=2 l min -1 is assumed to represent normal conditions during relaxed mechanical ventilation and conscious breathing. This value of Dw is lower than that reported by Duffin (2005) , implying that Dw is not the major drive of spontaneous ventilation in mechanically ventilated patients. A value of Dw=2 l min -1 , in combination with disfacilitation of -1 l min -1 from both central and peripheral drives also allows the simulation of apnea. Equation (13) describes the minute ventilation (V̇min) as V̇A plus ventilation of the serial dead space (VD) that is equal to the product of tidal volume (VT) and fR.
The model components B, D and E in Figure 1 , plus a single ventilated compartmental model of the lung have been previously coupled and implemented to simulate both dynamic and steady state conditions . The steady state model was modified adding extra state variables to account for alveolar concentration of O2 and CO2 in each of the ventilated compartments in Figure 1 (FETO 2(c1) , FETO 2(c2) , FETCO 2(c1) , FETCO 2(c2) ). The inclusion of CSF and respiratory control components ( Figures 1C and 1F) Reduction in ventilatory support (e.g. reduction in VT) will typically result in an increase in fR and hence a constant V̇A so as to maintain pHa within normal range. This pattern of reducing ventilatory support and increasing fR will depend for the individual patient upon two sets of factors, those which are directly measured such as acid-base status and metabolism (BEa and V̇CO 2 ), and those which are not, i.e. the individual patient's pulmonary gas exchange parameters (s, fA2 and f2) and chemoreflex response parameters (Sp, Sc, Tp, Tc). Therefore, two sensitivity analyses are performed here: 1) evaluation of model simulations to changes in measured factors (BEa and V̇CO 2 ); and 2) evaluation of model simulations to changes in chemoreflex response parameters (Sp, Sc, Tp, Tc). All sensitivity analysis simulations were performed assuming normal values for pulmonary gas exchange parameters. The details of these analyses are given below.
Evaluation of model simulations to changes in measured factors (BEa and V̇CO 2 )
The integrated model was used to simulate changes in ventilator support at different acid-base and metabolism in normal chemoreflex conditions. To explore the integrated model's behavior to different values of acid-base and V̇CO 2 , changes in fR were simulated on modifying VT in the range 200 to 1200 ml. Steady state values of fR were simulated for three acid-base conditions of blood: normal BEa (BEa=0.1 mmol l -1 ), metabolic acidosis (BEa=-4.2 mmol l -1
) and metabolic alkalosis (BEa=5.3 mmol l -1 ); at two V̇CO 2 levels (9.2 and 27.7 mmol min -1 ).
Evaluation of model simulations to changes in
chemoreflex response parameters (Sc, Sp, Tc and Tp) To explore the integrated model's behavior to different values of chemoreflex model parameters, changes in fR were simulated on modifying VT in the range 200 to 1200 ml. ); 2) normal BEa but increased V̇CO 2 (BEa=0.1 mmol l -1 and V̇CO 2 =27.7 mmol l -1 ); and 3) decreased BEa (metabolic acidosis) and increased V̇CO 2 (BEa=-4.2 mmol l -1 and V̇CO 2 =9.2 mmol l -1 ). With the last two representing conditions that augment the respiratory drive. In this way, the effect of the individual parameters could be shown as well as their interaction with the measured factors. To perform these simulations, model parameters were modified one at a time and keeping the remaining with normal values. Sensitivities (Sc and Sp) were varied by multiplying normal values by zero and two. Thresholds (Tc and Tp) were varied by adding or subtracting 5 nmol l -1 to normal values.
RESULTS
Evaluation of model simulations to changes in measured factors (BEa and V̇CO 2 )
Figure 2 illustrates simulations of the respiratory response to changes in VT for different values of measured factors BEa and V̇CO 2 . Figure 2A illustrates the effects of high and low BEa at normal V̇CO 2 , showing that metabolic alkalosis (high BEa) suppresses and metabolic acidosis (low BEa) augments respiratory drive. Figure 2B illustrates the effects of high and low BEa, at a high value of V̇CO 2 , showing that these effects act in combination such that for high V̇CO 2 all curves are shifted and respiratory drive augmented. (Sc, Sp, Tc, and Tp) Figure 3 illustrates simulations of the respiratory response to changes in VT for different values of non-measured factors, i.e. chemoreflex model parameters, at 3 conditions: normal BEa and normal V̇CO 2 ; normal BEa and increased V̇CO 2 ; and metabolic acidosis and increased V̇CO 2 . Plots are arranged in 3 columns and 2 rows; each column corresponding to the first, second and third conditions, and each row corresponding to changes in chemoreflex parameters Sc and Tc respectively. Solid lines represent simulations with normal parameter values with these lines systematically shifted for increased V̇CO 2 or for the combination of increased V̇CO 2 and decreased BEa, as also shown in Figure 2 .
Evaluation of model simulations to changes in chemoreflex response parameters
The first row of Figure 3 presents simulations of the respiratory response to changes in VT for different values of Sc. Figures 3A, 3B and 3C show that decreasing Sc suppresses and increasing Sc augments the respiratory drive, with a greater sensitivity to reducing Sc. The sensitivity of the respiratory response to changes in Sc is greater for increased V̇CO 2 and the combination of increased V̇CO 2 and decreased BEa.
The second row of Figure 3 presents simulations of the respiratory response to changes in VT for different values of Tc. Figures 3D, 3E and 3F show that decreasing Tc augments and increasing Tc suppress the respiratory drive. The sensitivity of the respiratory response to changes in Tc is greater for increased V̇CO 2 and the combination of increased 
DISCUSSION
This paper describes the integration of a mathematical model of chemoreflex respiratory control with models describing ventilation and pulmonary gas exchange, oxygenation and acid-base of blood, circulation, interstitial fluid and tissue buffering, and metabolism. The purpose of this integrated model is to be part of a DSS, providing advice on appropriate mechanical ventilation in support ventilation modes. In these ventilation modes pressure or volume support is determined by the clinician and set on the ventilator, with the patient responding in terms of fR dependent upon their individual physiological status. For mathematical models to be useful in aiding this decision they need to be complex enough to describe this individual response, and simple enough to be parameterized or tuned to the individual patient from routinely available clinical data.
The integrated model in Figure 1 includes (Lahiri and Forster, 2003) .
The balance between model simplicity and complexity necessitates a number of model assumptions in relation to the chemoreflex component. The CSF acid-base status is estimated using the model in figure 1C (Duffin, 2005) , assuming that O2 and CO2 molecules cross freely across the blood brain barrier. It is also assumed that there is no (short term) electrolyte exchange between blood and CSF such that when SIDcsf is calibrated to initial venous blood bicarbonate values 0] ), then SIDcsf remains fixed when simulating respiratory changes.
To our knowledge, this is the first time that a chemoreflex model has been integrated with models describing ventilation and pulmonary gas exchange, oxygenation and acid-base status of blood, circulation, interstitial fluid and tissue buffering, and metabolism for simulating the respiratory response to changes in mechanical ventilation for severely ill patients. Several other models have simulated respiratory control (for example: Ursino et al., 2001; Aittokallio et al., 2006 , Duffin, 2010 , however, these models have focused upon breathing pattern, and response to hypercapnia and hypoxia. In the context of mechanical ventilation, model complexity may be constrained to simulating steady state response to changes in ventilator support.
Inclusion of the previous models of INVENT are also important. The model of ventilation and pulmonary gas exchange is identifiable for the individual patient, allowing identification of pulmonary shunt, low V̇/Q̇ and high V̇/Q̇ (Karbing et al., 2011) . The blood acid-base model has been shown to simulate blood mixing accurately and includes consideration of the Bohr-Haldane effect, which is important in patients where pHa may be far from normal. In addition, the incorporation of an explicit compartment for interstitial fluid and tissue buffering, enables simulation of bicarbonate distribution between blood and interstitial fluid which is critical to correct simulation of in-vivo arterial CO2 levels ).
The integrated model assumes constant cardiac output (Q̇) and constant cerebral blood flow (CBF). In principle, Q̇ and CBF increase as a function of PaCO 2 . Increased CBF washes out CO2 from the CSF compartment (Mohan and Duffin, 1997;  19th IFAC World Congress Cape Town, South Africa. August 24-29, 2014 Ainslie and Duffin, 2009; Duffin, 2010) . Although CBF increases during hypercapnia, the CBF effects on ventilation sensitivity to CO2 are negligible (Ursino et al., 2001) , and not fully understood (Pandit et al., 2007) . Separation of the effects of CBF cannot be identified from the data describing changes in ventilator volume support, meaning that this level of complexity would not be helpful.
In conclusion, this paper has described the integration of Duffin's chemoreflex model into a set of physiological models. In doing so, it has been shown that the integrated model is sensitive to measured factors (BEa and V̇CO 2 ), and non-measured factors describing the central chemoreflex drive under conditions of normal pulmonary gas exchange and oxygenation. Central chemoreflex parameters SIDcsf, Tc and Sc may be identifiable from BEa, V̇CO 2 , and measured respiratory response to changes in ventilation support. Therefore identifying patient-specific chemoreflex drive, potentially enables the simulation of respiratory response to changes in ventilation support. Further evaluation of the integrated model with patient data including pulmonary gas exchange, acid-base status and metabolic abnormalities is required.
